Literature DB >> 16511650

Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.

Cornelia Kornblum1, Götz Lutterbey, Manuela Bogdanow, Kristina Kesper, Hans Schild, Rolf Schröder, Mike Peter Wattjes.   

Abstract

Myotonic Dystrophy Type 1 (DM1) and 2 (DM2) present with distinct though overlapping clinical phenotypes. Comparative imaging data on skeletal muscle involvement are not at present available. We used the novel technique of whole body 3.0 Tesla (T) Magnetic Resonance Imaging (MRI) to further characterize musculoskeletal features in DM2 and compared the results with DM1.MRI findings of 15 DM1 and 14 DM2 patients were evaluated with respect to patterns of skeletal muscle affection and clinical data using the Muscular Impairment Rating Scale (MIRS) and Medical Research Council scale (MRC). All DM1 patients had pathological MRI compared with only 5 DM2 patients. In contrast to DM2, DM1 patients showed a characteristic distribution of muscle involvement with frequent and early degeneration of the medial heads of gastrocnemius muscles, and a perifemoral semilunar pattern of quadriceps muscle affection sparing the rectus femoris. The most frequently affected muscles in DM1 were the medial heads of gastrocnemius, soleus, and vastus medialis muscles. In DM2, however, the erector spinae and gluteus maximus muscles were most vulnerable to degeneration. MRI data were in line with the clinical grading in 12 DM1 and 3 DM2 patients. In 3 DM1 and 5 DM2 patients, MRI detected subclinical muscle involvement. 9 DM2 patients with mild to moderate proximal muscle weakness and/or myalgias had normal MRI. Pathological MRI changes in DM2 emerged with increasing age and were restricted to women. Whole body 3.0T MRI is a sensitive imaging technique that demonstrated a characteristic skeletal muscle affection in DM1. In contrast, MRI was no reliable indicator for skeletal muscle involvement in mildly affected DM2 patients since myalgia and mild paresis were usually not reflected by MRI signal alterations.

Entities:  

Mesh:

Year:  2006        PMID: 16511650     DOI: 10.1007/s00415-006-0111-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  [Possibilities of whole-body MRI for investigating musculoskeletal diseases].

Authors:  S Lenk; S Fischer; I Kötter; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

2.  [MR-tomography and -spectroscopy of skeletal muscles using high magnetic field strengths].

Authors:  S O Rodiek; G Küther; H P Juretschke; D Hoepfel; N Schuff
Journal:  Rofo       Date:  1986-01

Review 3.  RNA pathogenesis of the myotonic dystrophies.

Authors:  John W Day; Laura P W Ranum
Journal:  Neuromuscul Disord       Date:  2004-11-26       Impact factor: 4.296

4.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

Review 5.  The peripheral apparatus of muscle pain: evidence from animal and human studies.

Authors:  T Graven-Nielsen; S Mense
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

6.  Magnetic resonance imaging of muscles in myotonic dystrophy.

Authors:  J Castillo; J M Pumar; J R Rodríguez; J M Prieto; L Arrojo; F Martínez; M Noya
Journal:  Eur J Radiol       Date:  1993-11       Impact factor: 3.528

7.  Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy.

Authors:  K Ricker; M C Koch; F Lehmann-Horn; D Pongratz; N Speich; K Reiners; C Schneider; R T Moxley
Journal:  Arch Neurol       Date:  1995-01

8.  [Results of muscular x-ray computed tomography in 145 cases of neuromuscular disease].

Authors:  G Serratrice; G Salamon; M Jiddane; J L Gastaut; J F Pellissier; J Pouget
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

9.  MRI in the study of distal primary myopathopies and of muscular alterations due to peripheral neuropathies: possible diagnostic capacities of MR equipment with low intensity field (0.2 T) dedicated to peripheral limbs.

Authors:  D Messineo; A Cremona; M Trinci; A Francia; A Marini
Journal:  Magn Reson Imaging       Date:  1998-09       Impact factor: 2.546

View more
  36 in total

1.  MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies.

Authors:  R Stramare; V Beltrame; R Dal Borgo; L Gallimberti; A C Frigo; E Pegoraro; C Angelini; L Rubaltelli; G P Feltrin
Journal:  Radiol Med       Date:  2010-02-22       Impact factor: 3.469

2.  Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1.

Authors:  Fabio Esposito; Emiliano Cè; Susanna Rampichini; Elena Monti; Eloisa Limonta; Barbara Fossati; Giovanni Meola
Journal:  Eur J Appl Physiol       Date:  2017-02-14       Impact factor: 3.078

Review 3.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

4.  Morphologic imaging in muscular dystrophies and inflammatory myopathies.

Authors:  Adrian Degardin; David Morillon; Arnaud Lacour; Anne Cotten; Patrick Vermersch; Tanya Stojkovic
Journal:  Skeletal Radiol       Date:  2010-05-07       Impact factor: 2.199

5.  Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy.

Authors:  Sunita Mathur; Donovan J Lott; Claudia Senesac; Sean A Germain; Ravneet S Vohra; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

6.  Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.

Authors:  Stojan Peric; Ruzica Maksimovic; Bojan Banko; Milica Durdic; Bogdan Bjelica; Ivo Bozovic; Yunus Balcik; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2017-07-29       Impact factor: 4.849

7.  Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.

Authors:  Arne Fischmann; Monika Gloor; Susanne Fasler; Tanja Haas; Rachele Rodoni Wetzel; Oliver Bieri; Stephan Wetzel; Karl Heinimann; Klaus Scheffler; Dirk Fischer
Journal:  J Neurol       Date:  2011-02-22       Impact factor: 4.849

Review 8.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

9.  Combined quantification of fatty infiltration, T 1-relaxation times and T 2*-relaxation times in normal-appearing skeletal muscle of controls and dystrophic patients.

Authors:  Benjamin Leporq; Arnaud Le Troter; Yann Le Fur; Emmanuelle Salort-Campana; Maxime Guye; Olivier Beuf; Shahram Attarian; David Bendahan
Journal:  MAGMA       Date:  2017-03-22       Impact factor: 2.310

Review 10.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.